On the contrary, Garmpis et al. indicated ER- and HER2-positive breast cancer specimens to exhibit higher HDAC-2 levels than PR-positive or triple negative breast cancer specimens, whereas DFS and OS showed a negative association with the overexpression of HDAC-2 [14]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.